Irvine, Mal
Stewart, Ashleigh
Pedersen, Bernadette
Boyd, Suzanah
Kefford, Richard
Rizos, Helen http://orcid.org/0000-0002-2094-9198
Article History
Received: 17 January 2018
Revised: 26 July 2018
Accepted: 30 July 2018
First Online: 20 September 2018
Conflict of interest
: Richard F. Kefford is on the advisory boards for BMS and Merck, makers of pembrolizumab, nivolumab and ipilimumab. The remaining authors declare that they have no conflict of interest.